Enrollment of UNC Health Care System (UNCHCS) patients into the multi-site Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study has reached 581 participants, exceeding the UNCHCS site’s original enrollment target of 500 participants.
Darren DeWalt, MD, MPH, chief of the division of general medicine and clinical epidemiology, recently discussed recruitment success for the Adaptable study, a three-year pragmatic clinical trial comparing two different doses of daily aspirin to evaluate which dose is more effective at preventing heart attacks and strokes for patients with cardiovascular disease.
“Recruitment is one of the most challenging aspects of many studies,” says DeWalt in the article. “Our Adaptable team worked closely with TraCS to streamline recruitment processes through email and MyUNCChart. These methods enabled us to exceed our goal with modest resources.”
Enrollment of UNC Health Care System patients in the multi-site Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study has reached 581 participants, according to UNC’s North Carolina Translational and Clinical Sciences Institute. This number exceeds the original enrollment target of 500 participants. The UNC Translational and Clinical Sciences Institute report identifies the long term recruitment goal of 15,000 participants.
The goal is to use health data generated in medical practice and health systems across the country to improve patient care and health outcomes. Learn more about the Adaptable Study.